¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦20Â÷ Á¤±âÇмú´ëȸ : 2022-04-30

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦20Â÷ Á¤±âÇмú´ëȸ : 2022-04-30
±³À°ÀÏÀÚ : 2022-04-30
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : 2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦20Â÷ Á¤±âÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ  
´ã´çÀÚ : °¡¿ÂÄÁº¥¼Ç
¿¬¶ôó : 02-2038-7988  
À̸ÞÀÏ : gaonpco@gaonpco.com      
±³À°Á¾·ù : ºñ´¢ÀÇÇаú      
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 30,000¿ø      
ºñ°í È¸¿ø: »çÀüµî·Ï 20,000¿ø(¿¬È¸ºñ 10,000¿ø Æ÷ÇÔ) ºñȸ¿ø: »çÀüµî·Ï 30,000¿ø °£È£»ç ¹× Àü°øÀÇ: »çÀüµî·Ï ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 09:00~09:40 Abstract Presentation I  ±èÁظð(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 09:40~09:55 Contemporary Microscopic Concepts of Pathophysiology of Recurrent Cystititis  ¿À¹Ì¹Ì(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 09:55~10:10 Global Perspective on Improving Patient Care in Uncomplicated UTI  Á¤ È«(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 10:10~10:25 Management of Paediatric Recurrent UTIs and Challenges in Special Patient Populations (VUR, BBD)  Á¤Àç¹Î(ºÎ»êÀÇ´ë) 
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 10:25~10:45 Panel Discussion  À¯±¸ÇÑ(°æÈñÀÇ´ë) 
È޽Ġ04-30  10:45~10:55 Coffee Break  () 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 10:55~11:10 New Antibacterial Approaches for Chronic Bacterial Prostatitis  Á¶ÀÎâ(±¹¸³°æÂûº´¿ø) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 11:10~11:25 Probiotics to Treat Chronic Bacterial Prostatitis  À±Çö½Ä(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 11:25~11:40 Non-Pharmacological Interventions for Treating CP/CPPS (e.g shockwave therapy )  ±è¿õºó(¼øõÇâÀÇ´ë) 
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 11:40~12:00 Panel Discussion  ÀÌÁ¤¿ì(°æÈñÀÇ´ë) 
È޽Ġ04-30  12:15~13:05 Á¡½É½Ä»ç  () 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:05~13:30 Mycoplasma Genitalium  À̱æÈ£(´Ü±¹ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:30~13:55 Biomarker for Interstitial Cystitis  ±è¿µÈ£(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 13:55~14:25 Urinary Tract Infection: Function and Use of the Innate Immune Response  ÃÖÇØ¿õ(°í·Á´ëÇб³ »ý¸í°úÇкÎ) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 14:25~15:05 Abstract Presentation II  À±Çϳª(ÀÌÈ­ÀÇ´ë) 
È޽Ġ04-30  15:05~15:20 Coffee Break  () 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:20~15:35 Sexually Transmitted Disease Surveillance (update on the epidemiology)  ÃÖÇö¼·(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:35~15:50 Key Changes in 2021 CDC Updates Guidance on Treatment of STIs  È²ÀÇâ(Àü³²ÀÇ´ë) 
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 15:50~16:05 Panel Discussion  ÀåÀÎÈ£(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:05~16:20 Problems in Care of Voiding Dysfunction and Infection Control in Korea  ¹è»ó¶ô(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:20~16:35 The Care Center for Voiding Dysfunction and Infection Disease  °íÇõÁØ(µ¿¾ÆÀÇ´ë) 
Åä·Ð 04-30 ¹é¹ü±è±¸ ±â³ä°ü ÄÁº¥¼Ç Ȧ 16:35~16:50 Panel Discussion  Á¤½ÂÀÏ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀǽǠ09:40~10:00 ¼º¸Å°³ °¨¿° : ¿øÀαÕ, °Ë»ç¹ý, Ä¡·á  ¾çÈñÁ¶(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀǽǠ10:00~10:20 ºñ´¢±â°è óġ¿Í ¼ö¼ú ÈÄ °¨¿° ¿¹¹æ (Ç×»ýÁ¦ »ç¿ëÀÇ ÀûÀÀÁõ)  ÃÖÁøºÀ(°¡Å縯ÀÇ´ë) 
Åä·Ð 04-30  10:20~10:30 ÁúÀÇ ÀÀ´ä  () 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀǽǠ10:30~10:50 COVID-19 ȯ°æ °ü¸® ½Ç¹« Áöħ: ȯ±â¿Í Ç¥¸é ¼Òµ¶  ¿Àº¸¶÷(¼­¿ï´ëÇб³º´¿ø °¨¿°°ü¸®¼¾ÅÍ) 
È޽Ġ04-30  10:50~11:05 Coffee Break  () 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀǽǠ11:05~11:25 ºñ´¢³»½Ã°æÀÇ Á¾·ù¿Í Ư¡ : À°¾ÈÀû ¼Ò°ß (Atlas)  À¯¼ºÇö(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀǽǠ11:25~11:45 ºñ´¢³»½Ã°æ ¼¼Ã´ ¹× ¼Òµ¶ Áöħ  ÇѽÃÇö(´Ü±¹´ëÇб³ õ¾Èº´¿ø °¨¿°°ü¸®ÆÀ) 
±³À°½Ã°£ 04-30 ¹é¹ü±è±¸ ±â³ä°ü ´ëȸÀǽǠ11:45~12:05 ºñ´¢³»½Ã°æ ¼Òµ¶Á¦ÀÇ Á¾·ù¿Í »ç¿ë¹æ¹ý  ÃÖÀº¼÷(Ãæ³²´ëÇб³º´¿ø) 
Åä·Ð 04-30  12:05~12:15 ÁúÀÇ ÀÀ´ä  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022³â ´ëÇÑ¿ä·Î»ý½Ä±â°¨¿°ÇÐȸ Á¦20Â÷ Á¤±âÇмú´ëȸ : 2022-04-30""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2022 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2022)(3ÀÏÂ÷) : 2022-04-30
´ÙÀ½±Û 2022 ´ëÇÑÇ÷¾×ÇÐȸ ¸¸¼º°ñ¼ö¼º¹éÇ÷º´(CML) ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2022-04-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 11 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 24 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 121 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 38 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 118 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 33 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 19 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 16 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 42 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 20 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 17 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 21 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 19 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷